In many states, you have just committed a crime with that comment. You really are a piece of work. A disgusting, shytty one at that. Shame on you.
You should get that CAPS key fixed, you complete and utter moron. OMG, where do you peeps come from? Funny as all get out!
Try familiarizing yourself with the merger agreement, before you make stupid statements like that.
There's always a breakup/termination fee built into these agreements, as a dis-incentive to walk away or go elsewhere for suitors. This one is actually low, compared to most others.
You're typical of the uninformed that inhabit these boards.
" double digit next 12 months is a given..."
You've repeatedly said that for 3 years now. When will it finally come true?
Maybe I'm too skeptical, but that listing seems to be weighted more towards the Optinose product, with barely a mention of Nuedexta. I also note that the launch in the EU of Optinose is described as a certainty, while Nuedexta's is described as a "potential launch."
Almost a year post approval in the EU, and nothing's happened. I'm baffled by this. And the silly talk about it being held back for the benefit of a sale of the company is so ludicrous it doesn't even deserve mention.
Thanks for this. Explains a lot of what we see on this "seemingly" dysfunctional board.
You post like this all the time. Do you think everyone is a noob here? You do have a record, you know that, right?
You guys are funny - dissing Karen. You might want to Google her, and see how successful she's been. She may not be great on TV, but she can run circles around anyone here. Her record speaks for itself. Dummies.
You clearly don't know how stop losses work, which means you are lying. Stock opened at 231+, which means you covered somewhere north of there, if at all (if you had actually been short).
Why create a new ID, just to make something up (which by the way makes you look like an idiot)?
Surprised to hear in the CC that they have enough cash to last until mid 2015. Positive (and amazing) that they aren't going to take advantage of this price level to grab some cash via an equity raise, like many companies would do.
I'm long RAD, btw.. Just so there's no confusion from those who like to accuse anyone with realistic expectations as being a short, lol.
And not enough earnings, too. Amazing that so many people try to equate apples and oranges. Both CVS and WAG both have over $3 in eps, and are priced appropriately based on a reasonable multiple and taking into account their respective o/s shares. RAD has one TENTH those earnings, and is almost priced at the same multiple.
May I ask what you're talking about? BW is not on my ignore list, so I think I've seen most of his posts. I don't remember seeing him or anyone else predict that report in advance. Am I missing the meaning of your post?